Latest News - The Aurum Institute

Prof Violet Chihota provides insights in TPT in World TB Day 2024 seminar

In commemoration of World TB Day 2024, esteemed experts convened at a virtual World TB Day Buildup Seminar to address the ongoing challenges and advancements in tuberculosis (TB) prevention. Hosted by...
World Tuberculosis Day: discover a Horizon 2020 project that is contributing to making a change in the field of tuberculosis treatment

...
USAID-Funded ACCELERATE Initiative to Boost Tuberculosis Elimination Efforts in South Africa

In a landmark move towards ending tuberculosis (TB) in South Africa, the U.S. Agency for International Development (USAID) has awarded the Aurum Institute US $47 million (approx. R886 million) to impl...
World TB Day 2024: focus on long-term effects

...
The Aurum Institute Calls for Sustained Investment to Ensure Progress in TB Care

For over two decades, Aurum, as an African-led organisation, has been at the forefront of the TB response, driving research and innovation, and supporting implementation of programmes to improve healt...
Revolutionising Pediatric TB Prevention: Insights from the Rifapentine Dispersible Formulation Webinar

In a monumental stride towards global tuberculosis (TB) prevention, a powerhouse collaboration of leading organisations recently convened a groundbreaking webinar on the dispersible formulation of rif...
Aurum Institute Parktown Hosts Inspiring Leadership Roadshow

The Aurum Institute Parktown recently marked the next stop in the Aurum Leadership Roadshow, underscoring Aurum leadership's dedication to the Aurum values of Excellence, Innovation, Integrity, Respe...
Bill Gates’ 5 predictions about AI that will change the world

...
Aurum's Commitment to Healthcare Access and Health Equity in Africa

Lagos, Nigeria, May 9, 2024 - The Aurum Institute participated in the 2024 Industry Engagement Forum, themed “Unlocking Healthcare Value Chains and Driving Investment through Partnerships: Accelerat...
IAVI’s Human Immunology Laboratory relocates samples to Africa, fulfilling capacity strengthening goal

...
World TB Month: PanTB-HM site tour

Tuberculosis remains a formidable global health challenge, causing significant morbidity and mortality worldwide. Even after successful treatment, many patients experience lasting lung damage, comprom...
Aurum conducts Training and QI tour in North West Province

The Aurum Institute's Training and Quality Improvement (QI) team is dedicated to enhancing engagement and performance across the North West Province, ensuring high-quality implementation of HIV/AIDS a...
Healthcare costs pushing more than half of SA’s TB patients into poverty

...
How global health institutions and funders can empower local researchers

...
Leadership Transition at Aurum: Prof. Charalambous and Prof. Chihota

It is with great pleasure that we announce the leadership transitions of Prof. Violet Chihota and Prof. Salome Charalambous within Aurum, effective 1 August 2024. Prof. Chihota, now serving as Group ...
Building Sustainable Quality Improvement in Africa’s Healthcare

At the ACQUIRE QI Leadership Forum in Kenya, The Aurum Institute’s Regional Director, Ms Lauren De Kock, led key discussions on how African countries can integrate quality improvement (QI) into thei...
HLA-A*23 Is Associated With Lower Odds of Acute Retroviral Syndrome in Human Immunodeficiency Virus Type 1 Infection: A Multicenter Sub-Saharan African Study

Lindquist, L., Kilembe, W., Karita, E., Price, M.A., Kamali, A., Kaleebu, P., Tang, J., Allen, S., Hunter, E., Gilmour, J. and Rowland-Jones, S.L., 2024, April. HLA-A* 23 Is Associated With Lower Odds...
Aurum's Community Engagement Manager joins Global TB Advisory Board

The Aurum Institute is proud to announce that Blossom Makhubalo, our Community Engagement Manager, has been appointed as one of the newest members of the Global Tuberculosis Community Advisory Board (...
Exposure to common infections may shape basal immunity and potentially HIV-1 acquisition amongst a high-risk population in Coastal Kenya.

Fwambah, L., Andisi, C., Streatfield, C., Bromell, R., Hare, J., Esbjörnsson, J., Ndung’u, T., Sanders, E.J., Hassan, A.S. and Nduati, E., 2024. Exposure to common infections may shape basal immuni...
. Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.

Moodie, Z., Andersen-Nissen, E., Grunenberg, N., Dintwe, O.B., Omar, F.L., Kee, J.J., Bekker, L.G., Laher, F., Naicker, N., Jani, I. and Mgodi, N.M., 2024. Safety and immunogenicity of a subtype C ALV...